Program Agenda

June 4, 2021
3:00pm - 4:00pm EDT

Abstract Presentations

Stephen Goldstone, MD

Results of a Phase 2 Study of VGX-3100 for the Treatment of HPV16 and/or HPV18 (HPV16/18) Positive Anal HSIL in HIV-negative Patients 
Edward Cachay MD, MAS

Use of computer-aided narrative content analysis to extract anal cytology diagnostic codes: a validation analysis

Ashish A. Deshmukh, PhD, MPH

Global burden of squamous cell carcinoma of the anus and HIV-attributable cases in 2020 

Cathy Eng, MD, FACP, FASCOA randomized phase III study of carboplatin plus paclitaxel +/- immune checkpoint inhibition in treatment-naive metastatic anal cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176)
Yuxin Liu, MD, PhD

HIV-infected women with HPV-associated anal cancer precursor: efficacy of electrocautery ablation and risk factors for recurrence

Emily Miller, APNA Case Report: An Examination of Possible Work-Related Cumulative Trauma from Repetitive Movement Related to Performing HRAs
Feixue Wei, PhDEpidemiology of anal human papillomavirus infection and high-grade lesions in 29 238 men, according to HIV status, sexuality, and age: a collaborative pooled analysis of 62 studies

 Invited Speaker

Biomarkers in Anal Cancer

Karen-Lise Garm Spindler, MD, Phd., DMSc 

Professor, Consultant GI Oncologist

Aarhus University Hospital Denmark

 IANS Business meeting (IANS members only)
4:00pm - 5:00pm EDT


The International Anal Neoplasia Society

P.O. Box 1543
Leesburg, Virginia 20177

Powered by Wild Apricot Membership Software